BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma

By small molecule compound screening targeting 142 epigenetic enzymes, researchers identified that bromodomain-containing protein BRD9 was a key chromatin regulator to orchestrate the stemness of pancreatic cancer stem cells.